Department for BioMedical Research (DBMR)

Blood - BLO

Porret Lab

Publications

Naomi Porret - Search Results - PubMed (nih.gov)

Gertrud Wiedemann - Search Results - PubMed (nih.gov)

  • Wiedemann, G., Bacher, U., Joncourt, R., Solly, F., Widmer, C.C., Zeerleder, S., Novak, U., Pabst, T., & Porret. N.A. (2024). A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications. International Journal of Molecular Sciences, 25(16), 8556. https://doi.org/10.3390/ijms25168556
  • Kartal-Kaess, M., Karow, A., Bacher, U., Pabst, T., Joncourt, R., Zweier, C., Kuehni, C. E., Porret, N. A., & Roessler, J. (2024). Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation. Pediatric hematology and oncology, 1–10. https://doi.org/10.1080/08880018.2024.2362885
  • Knosp, S., Kriegshauser, L., Tatsumi, K., Malherbe, L., Erhardt, M., Wiedemann, G., Bakan, B., Kohchi, T., Reski, R., & Renault, H. (2024). An ancient role for CYP73 monooxygenases in phenylpropanoid biosynthesis and embryophyte development. The EMBO journal, 10.1038/s44318-024-00181-7. https://doi.org/10.1038/s44318-024-00181-7
  • Perroud, C., Thurian, D., Andres, M., Künzi, A., Wiedemann, G., Zeerleder, S., Bacher, U., Pabst, T., Banz, Y., Porret, N., & Rebmann, E. (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), 912–921. https://doi.org/10.1002/hon.3208
  • Dorenkamp, M., Porret, N., Diepold, M., & Rovó, A. (2023). A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. Medicina (Kaunas, Lithuania), 59(11), 1953. https://doi.org/10.3390/medicina59111953
  • Messerli, C., Wiedemann, G., Porret, N., Nagler, M., Seipel, K., Jeker, B., Novak, U., Zeerleder, S., Bacher, U., & Pabst, T. (2023). Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma. Turkish journal of haematology : official journal of Turkish Society of Haematology, 40(3), 187–196. https://doi.org/10.4274/tjh.galenos.2023.2023.0136
  • Hu, R., Li, X., Hu, Y., Zhang, R., Lv, Q., Zhang, M., Sheng, X., Zhao, F., Chen, Z., Ding, Y., Yuan, H., Wu, X., Xing, S., Yan, X., Bao, F., Wan, P., Xiao, L., Wang, X., Xiao, W., Decker, E. L., … Wiedemann, G., … He, Y. (2023). Adaptive evolution of the enigmatic Takakia now facing climate change in Tibet. Cell, 186(17), 3558–3576.e17. https://doi.org/10.1016/j.cell.2023.07.003
  • Sanoyan, D. A., Seipel, K., Bacher, U., Kronig, M. N., Porret, N., Wiedemann, G., Daskalakis, M., & Pabst, T. (2023). Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients. BMC cancer, 23(1), 345. https://doi.org/10.1186/s12885-023-10824-3
  • Wittibschlager, V., Bacher, U., Seipel, K., Porret, N., Wiedemann, G., Haslebacher, C., Hoffmann, M., Daskalakis, M., Akhoundova, D., & Pabst, T. (2023). CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences, 24(6), 5688. https://doi.org/10.3390/ijms24065688
  • Andina, N., de Meuron, L., Schnegg-Kaufmann, A. S., Sarangdhar, M. A., Ansermet, C., Bombaci, G., Batta, K., Keller, N., Porret, N. A., Angelillo-Scherrer, A., Bonadies, N., & Allam, R. (2023). Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity. Journal of immunology (Baltimore, Md. 1950), 210(5), 580–589. https://doi.org/10.4049/jimmunol.2200412
  • Perroud, C., Porret, N., & Rovó, A. (2023). "The Long Journey of Unexplained Erythrocytosis": Erythrocytosis due to High-Oxygen Affinity Hemoglobinopathy - Hemoglobin Variant Little Rock (HBB: c.432C>A) - A Report of a Swiss Family and Review of the Literature. Acta haematologica, 146(4), 326–330. https://doi.org/10.1159/000530240
  • Rebmann Chigrinova, E., Porret, N. A., Andres, M., Wiedemann, G., Banz, Y., Legros, M., Pollak, M., Oppliger Leibundgut, E., Pabst, T., & Bacher, U. (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC medical genomics, 15(1), 203. https://doi.org/10.1186/s12920-022-01346-1
  • Heini, A. D., Bacher, U., Porret, N., Wiedemann, G., Legros, M., Stalder Zeerleder, D., Seipel, K., Novak, U., Daskalakis, M., & Pabst, T. (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17), 2747. https://doi.org/10.3390/cells11172747
  • Heini, A. D., Bacher, U., Kronig, M. N., Wiedemann, G., Novak, U., Zeerleder, S., Mansouri Taleghani, B., Daskalakis, M., & Pabst, T. (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), 1010–1012. https://doi.org/10.1038/s41409-022-01658-x
  • Vrotniakaite-Bajerciene, K., Tritschler, T., Jalowiec, K. A., Broughton, H., Brodard, J., Porret, N. A., Haynes, A., Rovo, A., Kremer Hovinga, J. A., Aujesky, D., & Angelillo-Scherrer, A. (2022). Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. Journal of clinical medicine, 11(14), 4188.
  • Jalowiec, K. A., Vrotniakaite-Bajerciene, K., Jalowiec, J., Frey, N., Capraru, A., Wojtovicova, T., Joncourt, R., Angelillo-Scherrer, A., Tichelli, A., Porret, N. A., & Rovó, A. (2022). JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital. Journal of clinical medicine, 11(12), 3393. https://doi.org/10.3390/jcm11123393
  • Rentsch, V., Seipel, K., Banz, Y., Wiedemann, G., Porret, N., Bacher, U., & Pabst, T. (2022). Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers, 14(10), 2516. https://doi.org/10.3390/cancers14102516
  • Seipel, K., Porret, N., Wiedemann, G., Jeker, B., Bacher, V. U., & Pabst, T. (2022). sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology, 44(4), 1463–1471. https://doi.org/10.3390/cimb44040098
  • Shumilov, E., Mazzeo, P., Zinkernagel, M. S., Legros, M., Porret, N., Romagna, L., Haase, D., Lenz, G., Novak, U., Banz, Y., Pabst, T., & Bacher, U. (2022). Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology (Toronto, Ont.), 29(2), 766–776. https://doi.org/10.3390/curroncol29020065
  • Lötscher, F., Seitz, L., Simeunovic, H., Sarbu, A. C., Porret, N. A., Feldmeyer, L., Borradori, L., Bonadies, N., & Maurer, B. (2022). Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease. Frontiers in immunology, 12, 800149. https://doi.org/10.3389/fimmu.2021.800149
  • Rempfer, C., Wiedemann, G., Schween, G., Kerres, K. L., Lucht, J. M., Horres, R., Decker, E. L., & Reski, R. (2022). Autopolyploidization affects transcript patterns and gene targeting frequencies in Physcomitrella. Plant cell reports, 41(1), 153–173. https://doi.org/10.1007/s00299-021-02794-2
  • Jalowiec, K. A., Vrotniakaite-Bajerciene, K., Capraru, A., Wojtovicova, T., Joncourt, R., Rovó, A., & Porret, N. A. (2021). NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients. Genes, 12(12), 1951. https://doi.org/10.3390/genes12121951
  • Müller, J., Porret, N. A., & Rüfer, A. (2021). Identification of a JAK2 FERM Domain Variant Associated With Hereditary Thrombocytosis. HemaSphere, 5(8), e626. https://doi.org/10.1097/HS9.0000000000000626
  • Chanias, I., Stojkov, K., Stehle, G. T., Daskalakis, M., Simeunovic, H., Njue, L. M., Schnegg-Kaufmann, A. S., Porret, N. A., Allam, R., Rao, T. N., Benz, R., Ruefer, A., Schmidt, A., Adler, M., Rovo, A., Balabanov, S., Stuessi, G., Bacher, U., Bonadies, N., & On Behalf Of The Swiss Mds Study Group (2021). Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers, 13(13), 3296. https://doi.org/10.3390/cancers13133296
  • Heini, A. D., Porret, N., Zenhaeusern, R., Winkler, A., Bacher, U., & Pabst, T. (2021). Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML. Cancers, 13(13), 3190. https://doi.org/10.3390/cancers13133190
  • Bonadies, N., Rovó, A., Porret, N., & Bacher, U. (2021). When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis. Journal of clinical medicine, 10(5), 1026. https://doi.org/10.3390/jcm10051026